Skip to main content

Table 2 Bone marrow findings subdivided after response to primary therapy

From: Presence of apoptotic and nonapoptotic disseminated tumor cells reflects the response to neoadjuvant systemic therapy in breast cancer

Bone marrow findings

Poor responder (n = 45)

Responder (n = 111)

 

Progressive disease (n = 5)

Stable disease (n = 40)

Stable disease + progressive disease (n = 45)

Partial remission (n = 87)

Complete remission (n = 24)

Partial remission + complete remission (n = 111)

Disseminated tumor cell negative (n = 56)

1 (20%)

11 (28%)

12 (26%)

34 (39%)

10 (42%)

44 (40%)

Only apoptotic cells (n = 17)

0 (0%)

2 (5%)

2 (4%)

11 (13%)

4 (17%)

15 (14%)

Nonapoptotic cells + apoptotic cells (n = 19)

0 (0%)

7 (18%)

7 (16%)

10 (12%)

2 (8%)

12 (11%)

Nonapoptotic cells (n = 64)

4 (80%)

20 (50%)

24 (52%)

32 (37%)

8 (33%)

40 (36%)